|
 |
|
|
 |
|
|
| | Bull | | Bear | |
Underlying
Code
|
Underlying
Name
|
No. of New CBBC
|
Total Issued Size
|
No. of New CBBC
|
Total Issued Size
|
| HSCEI | HS China Enterprises Index | 1 | 100,000,000 | 0 | 0 |
| HSI | Hang Seng Index | 1,005 | 189,126,000,000 | 1,087 | 205,286,000,000 |
| 00020 | SENSETIME-W | 14 | 770,000,000 | 2 | 140,000,000 |
| 00388 | HKEX | 31 | 2,680,000,000 | 3 | 300,000,000 |
| 00700 | TENCENT | 132 | 13,110,000,000 | 37 | 3,440,000,000 |
| 00939 | CCB | 5 | 330,000,000 | 0 | 0 |
| 00981 | SMIC | 38 | 4,020,000,000 | 8 | 1,060,000,000 |
| 01024 | KUAISHOU-W | 33 | 2,070,000,000 | 9 | 500,000,000 |
| 01093 | CSPC PHARMA | 16 | 750,000,000 | 1 | 40,000,000 |
| 01211 | BYD COMPANY | 20 | 1,270,000,000 | 11 | 700,000,000 |
| 01299 | AIA | 13 | 820,000,000 | 4 | 240,000,000 |
| 01347 | HUA HONG SEMI | 52 | 3,210,000,000 | 30 | 2,050,000,000 |
| 01788 | GUOTAI JUNAN I | 1 | 60,000,000 | 0 | 0 |
| 01801 | INNOVENT BIO | 9 | 360,000,000 | 1 | 40,000,000 |
| 01810 | XIAOMI-W | 53 | 5,280,000,000 | 27 | 2,920,000,000 |
| 02015 | LI AUTO-W | 5 | 340,000,000 | 0 | 0 |
| 02228 | XTALPI | 19 | 1,300,000,000 | 1 | 40,000,000 |
| 02269 | WUXI BIO | 9 | 880,000,000 | 2 | 200,000,000 |
| 02318 | PING AN | 27 | 2,240,000,000 | 15 | 1,080,000,000 |
| 02628 | CHINA LIFE | 22 | 2,790,000,000 | 13 | 1,990,000,000 |
|
|
|
 |
| Note: |
|
| This page shows all CBBC listed (including those already called CBBC) in the past 1 calendar month from today. |
|
| This page showing those eligible underlying for CBBC issuance only includes the Hang Seng Index and Hang Seng China Enterprises Index, and Hong Kong listed stocks as announced by Hong Kong Exchanges and Clearings Limited periodically. |
|
| The above information is updated once on every trading day. |
|
|
|
Investment involves risks. The price of Callable Bull/Bear Contracts ("CBBC") may move up or down rapidly, and may become valueless, resulting in a total loss of investor's investment. There is an inherent risk that losses may be incurred rather than profit made as a result of buying and selling CBBC. CBBC has a mandatory call feature. CBBC must be terminated when the spot price / spot level of the underlying asset reaches or goes beyond the call price / call level prior to expiry, in which case, the holder of CBBC will or is likely to, lose all the investment. Investors bear the credit risk of the issuer and have no recourse to Hang Seng Bank Limited. Investors should make their own risk assessment and seek independent professional investment or other advice where necessary with respect to any exposure to derivative CBBC. Investors should refer to the relevant CBBC's listing documents (including but not limited to the full text of the risk factors stated therein) in detail and understand the nature, terms and risks of the relevant CBBC before making any investment decision.
|
|
|
|
By viewing this website or using any information or functions of this website, you are deemed to acknowledge that you agree to the terms of use as
stated here.
|
|
|
 |
|
|
|
|
|
|
| HSI | 26,519.78 |  327.54 |
| HSCEI | 8,963.32 | 85.06 |
|
Index last updated: 05 Feb 202613:25 |
|
|
|
|
|
